Endometriosis
Conditions
Interventions
Observation group:Wenjing Decoction + Dydrogesterone
Control group :Dydrogesterone
Placebo group : Placebo
Sponsors
the Third Affiliated Hospital of Zhejiang Chinese University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: a Complaints of pelvic pain, with a VAS score of 4 or above; b Meet the diagnostic criteria for deep infiltrating endometriosis; c Comply with the syndrome of cold coagulation and blood stasis; d Female, between 18-45 years old; menstrual cycle is regular, the menstrual cycle is 21-35 days; e Those who have not taken hormone drugs in the past 3 months; f There is no pregnancy plan during the medication period, and contraceptive contraception is used; g Those who voluntarily participate in this trial and have signed an informed consent form.
Exclusion criteria
Exclusion criteria: a Combined with adenomyosis, pelvic inflammatory mass, and endometriotic cyst diameter = 4cm; b DIE The lesion penetrates the rectal mucosa and bladder mucosa, and the lesion compresses the ureter to cause transfusion. Urinary tube dilation, hydronephrosis; c Patients with malignant tumors of reproductive organs or other malignant tumors; d People with serious or mental illnesses such as cardiovascular, cerebrovascular, liver, kidney or hematopoietic system; e Patients with endometriosis who underwent surgical treatment within 3 months before enrollment; f Patients planning pregnancy, pregnancy or lactation in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lesion size;EHP-5;Serum CA125 level;Serum CA125 level; | — |
Countries
China
Contacts
Public ContactJIANG Yanjiao
Outcome results
None listed